vcfirmsdirectory.com

Venture capital · Early stage

VESALIUS BIOCAPITAL IV Partners Sarl

Luxembourg-based venture capital manager running its fourth fund, which backs European life sciences businesses spanning biopharma, devices, diagnostics and digital health.

ConternRegistered · Luxembourg
New investments · 12 months
Fund vehiclesPublic
2
2 active · EuVECA
First chequePublic
€10M–€15M
From the firm’s website
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:07 CETSources: ESMA register · vesaliusbiocapital-4.com
VESALIUS BIOCAPITAL IV Partners SarlLuxembourg

Investment activity

Round-by-round activity is part of PRO

See every round VESALIUS BIOCAPITAL IV Partners Sarl joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is VESALIUS BIOCAPITAL IV Partners Sarl right for your round?

Is VESALIUS BIOCAPITAL IV Partners Sarl a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
2
2 active · EuVECA
ESMA register
On the register sincePublic
2023
23 Nov 2023
ESMA register of EuVECA managers
First chequePublic
€10M–€15M
From the firm’s website
vesaliusbiocapital-4.com
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (ESMA register).

VESALIUS BIOCAPITAL IV INVESTMENTS S.A., SICAR-compartiment virtuelEuVECA · Active · Luxembourg
VESALIUS BIOCAPITAL IV S.C.A., SICAR-compartiment virtuelEuVECA · Active · Luxembourg
Deployed (new cheques)
Next fund expected

Latest investments

Rounds VESALIUS BIOCAPITAL IV Partners Sarl joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round VESALIUS BIOCAPITAL IV Partners Sarl joined

Round sizes, VESALIUS BIOCAPITAL IV Partners Sarl’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

NutriumENYO PharmaInflammatixHepaRegeniXinHEARTCognivia

Portfolio and exits

Every company VESALIUS BIOCAPITAL IV Partners Sarl backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where VESALIUS BIOCAPITAL IV Partners Sarl puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet VESALIUS BIOCAPITAL IV Partners Sarl

Events where VESALIUS BIOCAPITAL IV Partners Sarl’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet VESALIUS BIOCAPITAL IV Partners Sarl’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

10 Jul 2024New deal
6 May 2024New deal
23 Nov 2023RegisterVESALIUS BIOCAPITAL IV PARTNERS SARL registered as a EuVECA manager.ESMA register · public record

Founders also look at

Frequently asked questions

VESALIUS BIOCAPITAL IV Partners Sarl is based in Luxembourg. It also has an office in Contern.

2 fund vehicles are on public registers (ESMA register), including VESALIUS BIOCAPITAL IV INVESTMENTS S.A., SICAR-compartiment virtuel and VESALIUS BIOCAPITAL IV S.C.A., SICAR-compartiment virtuel.

Stages: Early stage. Sectors: Life sciences, Health tech, Biotech, Medtech. From the firm’s own website.

Backs European biopharma and healthtech companies that tackle unmet medical needs and are protected by solid IP. Builds a diversified book across therapeutic areas, development stages, technologies and countries, works hands-on with entrepreneurs, funds them step by step, keeps reserves for follow-ons and usually leads or co-leads rounds. From the firm’s own website.

€10M to €15M per investment, according to the firm’s own website.

VESALIUS BIOCAPITAL IV Partners Sarl lists 6 portfolio companies on its website, including Nutrium, ENYO Pharma, Inflammatix, HepaRegeniX and inHEART.

Firms whose websites list some of the same companies include Cleverage Capital, Khosla Ventures and Marram Ventures.

Know before VESALIUS BIOCAPITAL IV Partners Sarl’s next round is announced.

PRO tracks VESALIUS BIOCAPITAL IV Partners Sarl’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

VESALIUS BIOCAPITAL IV Partners SarlGet VESALIUS BIOCAPITAL IV Partners Sarl’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.